SENS
Senseonics Holdings, Inc.
NASDAQ · Healthcare · Medical - Devices · US
$9.41
+6.15%Price chart
Oct 6Oct 9Oct 14Oct 19Oct 22Oct 27Oct 30Nov 4
Key dataNov 4, 2026
Open$9.06
From 52W high−9.04%
Volume280027.00
Market cap$497.28M
P/E (TTM)—
P/S (TTM)10.2x
Div yield—
Key dataNov 4, 2026
Open
$9.06
From 52W high
−9.04%
Volume
280027.00
Market cap
$497.28M
ValuationView details →
P/E (Fwd)
—
EV/EBITDA
−4.1x
P/E (TTM)
—
RSI (14)
53.9
MomentumView details →
1D Return
+6.15%
YTD Return
+66.11%
Similar companies
Latest newsMore news →
Senseonics Holdings, Inc. initiated the first-in-human clinical study of its investigational, transmitter-free, one-year Freedom continuous glucose monitoring system.9d agoSenseonics Holdings announced that it plans to release its third-quarter 2026 financial results after market close on November 9, 2026.14d agoBeta Bionics integrated Senseonics' Eversense 365 continuous glucose monitor into its iLet automated insulin delivery ecosystem.36d ago